Filing Flows › Cryoport (CYRX) › Q1 2025
Cryoport (CYRX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Cryoport (CYRX) reported revenue of $41.0M for the first quarter 2025 (Q1 2025), +10% from a year earlier and -31% from the quarter before. Operating margin was -23.1%, net loss $12.0M (29.2% of revenue).
Cryoport, Q1 2025: revenue $41.0M (+10% year over year), operating margin -23.1%, net loss $12.0M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $41.0M | -31% | +10% |
| Operating profit | −$9.5M | — | — |
| Net earnings | −$12.0M | — | — |
| Operating cash flow | −$4.3M | — | — |
What changed
Revenue was $41.0M in Q1 2025, up 10% year over year and down 31% from the previous quarter. BioLogistics Solutions was the largest line at 45% of revenue. BioLogistics Solutions added $2.6M year over year (up 16%), 69% of the total change.
Gross margin was 45.4%, up 5.0 points from a year earlier. Operating costs exceeded revenue by $9.5M, an operating margin of -23.1%. Operating expenses fell 14% while revenue rose 10%. The quarter ended with a net loss of $12.0M, narrower than the previous quarter's $18.7M loss.
Operating cash flow was −$4.3M. Non-cash charges added back $7.6M of depreciation and amortization and $3.1M of share-based compensation. Working capital and other items used $3.1M. Capital expenditures of $3.2M exceeded it, leaving free cash flow of −$7.5M.
Questions
What was Cryoport's revenue in the first quarter 2025?
Cryoport (CYRX) reported revenue of $41.0M for the first quarter 2025 (Q1 2025), +10% from a year earlier and -31% from the quarter before.
Was Cryoport profitable in the first quarter 2025?
Operating loss was $9.5M (-23.1% of revenue) and net loss $12.0M.
Source: Cryoport 10-Q on SEC EDGAR.